TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)

[TPI Reports Record Second Quarter Fiscal Year 2011 Financial Results February 14, 2011 CHENGDU, China, Feb. 14, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals, announced the financial results for the second quarter of Fiscal Year 2011. Second quarter fiscal] [Tianyin Pharmaceutical, Inc. Second Quarter Fiscal Year 2011 Earnings Results February 15, 2011 Operator: Good morning, ladies and gentleman, and thank you for standing by. Welcome to the Tianyin Pharmaceutical Inc. Second Quarter Earnings Conference Call. At this time, all participants are in listen-only mode, and following the presentation, instructions will be given for the question and answer session. Should] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT February 15, 2011 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 Section 7 –]

By | 2016-03-27T21:22:28+00:00 February 22nd, 2011|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments
Read More

TPI [TIANYIN PHARMACEUTICAL] 8-K: TPI Reports Record Second Quarter Fiscal Year 2011

[TPI Reports Record Second Quarter Fiscal Year 2011 Financial Results February 14, 2011 CHENGDU, China, Feb. 14, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals, announced the financial results for the second quarter of Fiscal Year 2011. Second quarter fiscal] [Tianyin Pharmaceutical, Inc. Second Quarter Fiscal Year 2011 Earnings Results February 15, 2011 Operator: Good morning, ladies and gentleman, and thank you for standing by. Welcome to the Tianyin Pharmaceutical Inc. Second Quarter Earnings Conference Call. At this time, all participants are in listen-only mode, and following the presentation, instructions will be given for the question and answer session. Should] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT February 15, 2011 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 Section 7 –]

By | 2016-03-27T21:24:17+00:00 February 22nd, 2011|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments
Read More

TPI [TIANYIN PHARMACEUTICAL] SC 13G: for a reporting persons initial filing on this

[for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose (Act) or otherwise subject to]

By | 2016-03-27T21:28:56+00:00 February 16th, 2011|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments
Read More

TPI [TIANYIN PHARMACEUTICAL] SC 13G: (Original Filing)

[for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose (Act) or otherwise subject to]

By | 2016-03-27T21:28:03+00:00 February 16th, 2011|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments
Read More

TPI [TIANYIN PHARMACEUTICAL] SC 13G: (Original Filing)

[(Name of Issuer) Common Stock (Title of Class of Securities) 88630M104 (CUSIP Number) December 31, 2010 (Date of Event Which Requires Filing of this Statement) [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * CUSIP No. 88630M104 1. NAMES OF REPORTING PERSONS 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 3. SEC USE ONLY]

By | 2016-03-27T21:30:28+00:00 February 14th, 2011|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments
Read More

TPI [TIANYIN PHARMACEUTICAL] SC 13G: (Name of Issuer) Common Stock (Title of Class

[(Name of Issuer) Common Stock (Title of Class of Securities) 88630M104 (CUSIP Number) December 31, 2010 (Date of Event Which Requires Filing of this Statement) [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * CUSIP No. 88630M104 1. NAMES OF REPORTING PERSONS 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 3. SEC USE ONLY]

By | 2016-03-27T21:31:45+00:00 February 14th, 2011|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments
Read More

TPI [TIANYIN PHARMACEUTICAL] SC 13G: (Original Filing)

[(Name of Issuer) Common Stock (Title of Class of Securities) 88630M104 (CUSIP Number) December 31, 2010 (Date of Event Which Requires Filing of this Statement) [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * CUSIP No. 88630M104 1. NAMES OF REPORTING PERSONS 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 3. SEC USE ONLY]

By | 2016-03-27T21:32:43+00:00 February 14th, 2011|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments
Read More
Skip to toolbar